This week, we're reading about reactions to TrumpRx's launch, a call by CMS Administrator Mehmet Oz for people to get measles vaccinations, and the decision by Hims & Hers to stop offering its semaglutide pill following threats of legal action, including by Novo Nordisk, which produces Wegovy.
Before we get to the roundup, though, be sure to check out this interview from Drug Topics with NCPA's Anne Cassity on what will come next in the fight for PBM reforms and the maneuvering PBMs might engage in to skirt the rules.
Here's what else we're reading:
- MedCity News: Employers Celebrated PBM Reform. The Reality Is More Complicated
- Roll Call: Trump's drug pricing plan gets lukewarm reception
- Becker's Hospital Review: TrumpRx prices not always the lowest option
- The New York Times: Oz Offers Forceful Call for Vaccination as Measles Becomes More Dire
- CNBC: Hims & Hers pulls copycat weight-loss pill after threats of legal action
- Healthcare Dive: HHS scraps 340B rebate pilot in win for hospitals
- The Salt Lake Tribune: In Utah, Mark Cuban challenges Trump: Break up big insurers and ‘health care costs drop like that'
- News From the States: Georgia pharmacists would be allowed to prescribe contraception under bill seeking to expand access
- News From the States: Bill prohibiting mailing abortion pills to West Virginia heads to state Senate for a vote
- Fox 56 WOLF: Local pharmacy fills meds after hospital fire leaves confusion in wake
NCPA
